Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 48, Issue 4, 2000, Pages 1041-1050

  Grabenbauer, Gerhard G ^a,b   Mühlfriedel, Christine ^a   Rödel, Franz ^a   Niedobitek, Gerald ^a   Hornung, Joachim ^a   Rödel, Claus ^a   Martus, Peter ^a   Iro, Heiner ^a   Kirchner, Thomas ^a   Steininger, Helmuth ^a   Sauer, Rolf ^a   Weidenbecher, Manfred ^a   Distel, Luitpold ^c  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c University Hospital ^*

Author keywords

Head and neck tumors; p53; Proliferation; Radiotherapy; Surgery

Indexed keywords

BIOCHEMICAL MARKER; KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OROPHARYNX CARCINOMA; PALATE DISEASE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RECURRENCE RISK; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TONGUE CARCINOMA; TONSIL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PALATAL NEOPLASMS; PALATE, SOFT; RADIOTHERAPY DOSAGE; TONGUE NEOPLASMS; TONSILLAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034333142     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00737-9     Document Type: Article

References (48)

1. Failure in the neck following multimodality treatment for advanced head and neck cancer
2. Planned combination of surgery and radiation in the treatment of advanced primary head and neck cancer
3. Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck; A matched pair analysis
4. The efficacy of postoperative radiotherapy for advanced head and neck cancer; Quality of evidence
5. Adjuvant radiotherapy for squamous cell carcinoma of ther tongue base; Improved loco-regional disease control compared with surgery alone
6. Early closure of a randomized trial; surgery and postoperative radiotherapy versus radiotherapy in the management of intraoral tumors
7. Altered fractionation in the management of head and neck cancer
8. Impact of risk factors and total time for combined surgery and radiotherapy on the outcome of patients with advanced head and neck cancer
9. A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region; Clinical and treatment parameters as prognostic factors
10. Further analysis of the time factor in squamous cell carcinoma of the tonsillar region
11. Loss of local control with prolongation in radiotherapy
12. Re-analysis of the time factor in local control by radiotherapy of T3 T4 squamous cell carcinoma of the larynx
13. Interruptions adversely affect local control and survival with hyperfractionated radiotherapy of carcinomas of the upper respiratory and digestive tract
14. Split-course versus continuous course irradiation in the postoperative setting for squamous cell carcinoma of the head, and neck
15. Radical surgery and postoperative split-course radiotherapy in squamous cell carcinoma of the head and neck
16. An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity
17. Split-course accelerated hyperfractionation radiotherapy for advanced head, and neck cancer; Influence of split time and overall treatment time on local control
18. Applying radiobiological principles to combined modality treatment of head and neck cancer-the time factor
19. Ki-67 and p53 in T2 laryngeal cancer
20. Markers of radioresistance in squamous cell carcinomas of the head and neck; A clinicopathologic and immunohistochemical study
21. Nodal CT density, and total tumour volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer
22. Predicting recurrence and survival in patients with laryngeal cancer by means of DANN cytometry, tumor front grading, and proliferation markers
23. Immunohistochemical detection of tumor growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues
24. New Ki-67 equivalent murine monoclonal antibodies (MIB1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 bp repetitive elements encoding for the Ki-67 epitope
25. Participation of the p53 protein in the cellular response to DNA damage
26. P53, guardian of the genome
27. Increased radiosensitivity is associated with p53 mutations in cell lines derived from oral cavity carcinoma
28. Prognostic significance of p53 gene mutations in laryngeal cancer
29. p53 status, and the efficacy of cancer therapy in vivo
30. p53 mutations increase resistance to ionizing radiation
31. p53 mutations, and locoregional treatment failure in head, and neck squamous cell carcinoma
32. p53 mutation as a prognostic marker in advanced laryngeal carcinoma
33. Non parametric estimation from incomplete observations
34. Regression models and life tables
35. P53 expression and cell proliferation in squamous cell carcinomas of the head and neck
36. Cell cycle regulation in response to DNA damage in mammalian cells; A historical perspective
37. The p53 tumor suppressor gene
38. Mutations in p53 tumor suppressor gene; Clues to cancer etiology and molecular pathogenesis
39. p53 overexpression in head, and neck carcinoma, and radiotherapy results
40. Tumor proliferation, p53 expression, and apoptosis in laryngeal carcinoma. Relations to the results of radiotherapy
41. Prognostic role of p53 protein expression in epidermiod carcinoma of the anal canal
42. The effects of combining ionizing radiation and retroviral p53 therapy in nasopharyngeal carcinoma
43. P53 overexpression correlates with increased survival in patients with squamous carcinoma of the tongue base
44. Regulation of p53 stability
45. Simultaneous radiochemotherapy versus radiotherapy alone in stage III/IV carcinoma of the head and neck
46. Spincter preservation with chemoradiation in anal canal carcinoma. Abdominoperineal resection in selected cases?